Annual CFF
$10.59 M
-$5.72 M-35.09%
31 December 2023
Summary:
BioLife Solutions annual cash flow from financing activities is currently $10.59 million, with the most recent change of -$5.72 million (-35.09%) on 31 December 2023. During the last 3 years, it has fallen by -$91.49 million (-89.62%). BLFS annual CFF is now -89.62% below its all-time high of $102.08 million, reached on 31 December 2020.BLFS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$1.04 M
-$337.00 K-47.87%
30 September 2024
Summary:
BioLife Solutions quarterly cash flow from financing activities is currently -$1.04 million, with the most recent change of -$337.00 thousand (-47.87%) on 30 September 2024. Over the past year, it has dropped by -$1.65 million (-271.22%). BLFS quarterly CFF is now -101.29% below its all-time high of $80.58 million, reached on 30 September 2020.BLFS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$7.14 M
-$1.65 M-18.75%
30 September 2024
Summary:
BioLife Solutions TTM cash flow from financing activities is currently $7.14 million, with the most recent change of -$1.65 million (-18.75%) on 30 September 2024. Over the past year, it has increased by +$7.02 million (+5615.20%). BLFS TTM CFF is now -93.05% below its all-time high of $102.80 million, reached on 31 March 2021.BLFS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLFS Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.1% | -271.2% | +5615.2% |
| 3 y3 years | -89.6% | +1.6% | +1092.7% |
| 5 y5 years | -62.4% | -240.1% | +972.3% |
BLFS Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -89.6% | +481.3% | -106.0% | +50.5% | -57.8% | +271.1% |
| 5 y | 5 years | -89.6% | +481.3% | -101.3% | +50.5% | -93.0% | +271.1% |
| alltime | all time | -89.6% | +481.3% | -101.3% | +51.5% | -93.0% | +271.1% |
BioLife Solutions Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.04 M(+47.9%) | $7.14 M(-18.8%) |
| June 2024 | - | -$704.00 K(-26.1%) | $8.79 M(-13.8%) |
| Mar 2024 | - | -$952.00 K(-109.7%) | $10.20 M(-3.7%) |
| Dec 2023 | $10.59 M(-35.1%) | $9.84 M(+1518.6%) | $10.59 M(+8372.8%) |
| Sept 2023 | - | $608.00 K(-13.6%) | $125.00 K(-99.3%) |
| June 2023 | - | $704.00 K(-225.3%) | $16.93 M(+6.2%) |
| Mar 2023 | - | -$562.00 K(-10.1%) | $15.94 M(-2.3%) |
| Dec 2022 | $16.32 M(-687.3%) | -$625.00 K(-103.6%) | $16.32 M(+10.0%) |
| Sept 2022 | - | $17.41 M(-6124.6%) | $14.84 M(-508.4%) |
| June 2022 | - | -$289.00 K(+59.7%) | -$3.63 M(-13.0%) |
| Mar 2022 | - | -$181.00 K(-91.4%) | -$4.17 M(+50.3%) |
| Dec 2021 | -$2.78 M(-102.7%) | -$2.10 M(+99.0%) | -$2.78 M(-563.8%) |
| Sept 2021 | - | -$1.06 M(+27.3%) | $599.00 K(-99.3%) |
| June 2021 | - | -$831.00 K(-168.3%) | $82.24 M(-20.0%) |
| Mar 2021 | - | $1.22 M(-4.4%) | $102.80 M(+0.7%) |
| Dec 2020 | $102.08 M(+6295.9%) | $1.27 M(-98.4%) | $102.08 M(+1.0%) |
| Sept 2020 | - | $80.58 M(+308.4%) | $101.07 M(+376.0%) |
| June 2020 | - | $19.73 M(+3910.6%) | $21.23 M(+1011.1%) |
| Mar 2020 | - | $492.00 K(+84.3%) | $1.91 M(+19.7%) |
| Dec 2019 | $1.60 M(-94.3%) | $267.00 K(-64.1%) | $1.60 M(-294.9%) |
| Sept 2019 | - | $743.00 K(+81.7%) | -$819.00 K(-103.9%) |
| June 2019 | - | $409.00 K(+131.1%) | $21.12 M(-25.4%) |
| Mar 2019 | - | $177.00 K(-108.2%) | $28.30 M(+0.6%) |
| Dec 2018 | $28.15 M(+486.9%) | -$2.15 M(-109.5%) | $28.15 M(-15.7%) |
| Sept 2018 | - | $22.68 M(+198.7%) | $33.38 M(+199.4%) |
| June 2018 | - | $7.59 M(>+9900.0%) | $11.15 M(+199.4%) |
| Mar 2018 | - | $18.00 K(-99.4%) | $3.72 M(-22.4%) |
| Dec 2017 | $4.80 M(+51.4%) | $3.08 M(+577.7%) | $4.80 M(+78.4%) |
| Sept 2017 | - | $454.80 K(+169.6%) | $2.69 M(-20.0%) |
| June 2017 | - | $168.70 K(-84.5%) | $3.36 M(-20.8%) |
| Mar 2017 | - | $1.09 M(+11.9%) | $4.25 M(+34.1%) |
| Dec 2016 | $3.17 M(+758.7%) | $975.00 K(-13.5%) | $3.17 M(+28.7%) |
| Sept 2016 | - | $1.13 M(+7.1%) | $2.46 M(+81.8%) |
| June 2016 | - | $1.05 M(+8599.2%) | $1.35 M(+280.3%) |
| Mar 2016 | - | $12.10 K(-95.5%) | $355.90 K(-3.5%) |
| Dec 2015 | $368.80 K(-97.3%) | $268.80 K(+1244.0%) | $368.70 K(+258.3%) |
| Sept 2015 | - | $20.00 K(-63.6%) | $102.90 K(+24.1%) |
| June 2015 | - | $55.00 K(+120.9%) | $82.90 K(-23.6%) |
| Mar 2015 | - | $24.90 K(+730.0%) | $108.50 K(-99.2%) |
| Dec 2014 | $13.68 M(>+9900.0%) | $3000.00(>+9900.0%) | $13.68 M(+0.0%) |
| Sept 2014 | - | $0.00(-100.0%) | $13.68 M(-0.2%) |
| June 2014 | - | $80.60 K(-99.4%) | $13.70 M(+0.6%) |
| Mar 2014 | - | $13.60 M(>+9900.0%) | $13.62 M(>+9900.0%) |
| Dec 2013 | $50.50 K(-89.4%) | $0.00(-100.0%) | $50.50 K(0.0%) |
| Sept 2013 | - | $25.00 K(>+9900.0%) | $50.50 K(+98.0%) |
| June 2013 | - | $0.00(-100.0%) | $25.50 K(-92.2%) |
| Mar 2013 | - | $25.50 K(>+9900.0%) | $325.50 K(-31.5%) |
| Dec 2012 | $475.00 K(-56.6%) | $0.00(0.0%) | $475.00 K(-32.1%) |
| Sept 2012 | - | $0.00(-100.0%) | $700.00 K(-26.3%) |
| June 2012 | - | $300.00 K(+71.4%) | $950.00 K(+3.3%) |
| Mar 2012 | - | $175.00 K(-22.2%) | $920.00 K(-16.0%) |
| Dec 2011 | $1.09 M(-4.4%) | $225.00 K(-10.0%) | $1.09 M(-6.0%) |
| Sept 2011 | - | $250.00 K(-7.4%) | $1.17 M(0.0%) |
| June 2011 | - | $270.00 K(-22.9%) | $1.17 M(-6.4%) |
| Mar 2011 | - | $350.00 K(+18.6%) | $1.25 M(+8.7%) |
| Dec 2010 | $1.15 M(-59.5%) | $295.00 K(+18.0%) | $1.15 M(-0.7%) |
| Sept 2010 | - | $250.00 K(-28.6%) | $1.15 M(-24.5%) |
| June 2010 | - | $350.00 K(+40.0%) | $1.53 M(-8.9%) |
| Mar 2010 | - | $250.00 K(-17.4%) | $1.68 M(-40.7%) |
| Dec 2009 | $2.83 M | $302.60 K(-51.6%) | $2.83 M(-9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2009 | - | $625.00 K(+25.0%) | $3.13 M(+4.2%) |
| June 2009 | - | $500.00 K(-64.3%) | $3.00 M(0.0%) |
| Mar 2009 | - | $1.40 M(+133.3%) | $3.00 M(+36.2%) |
| Dec 2008 | $2.20 M(-20.0%) | $600.00 K(+20.0%) | $2.20 M(+37.3%) |
| Sept 2008 | - | $500.00 K(0.0%) | $1.60 M(-23.8%) |
| June 2008 | - | $500.00 K(-17.0%) | $2.10 M(-19.2%) |
| Mar 2008 | - | $602.30 K(>+9900.0%) | $2.60 M(-5.4%) |
| Dec 2007 | $2.75 M(+304.0%) | $1700.00(-99.8%) | $2.75 M(+7.3%) |
| Sept 2007 | - | $1.00 M(0.0%) | $2.56 M(+64.2%) |
| June 2007 | - | $1.00 M(+33.4%) | $1.56 M(+8.6%) |
| Mar 2007 | - | $750.10 K(-503.5%) | $1.44 M(+111.1%) |
| Dec 2006 | $681.30 K(+201.6%) | -$185.90 K(+7645.8%) | $681.30 K(-21.0%) |
| Sept 2006 | - | -$2400.00(-100.3%) | $862.60 K(-21.3%) |
| June 2006 | - | $876.60 K(<-9900.0%) | $1.10 M(+400.5%) |
| Mar 2006 | - | -$7000.00(+52.2%) | $218.90 K(-3.1%) |
| Dec 2005 | $225.90 K(-132.0%) | -$4600.00(-102.0%) | $225.90 K(-2.0%) |
| Sept 2005 | - | $230.50 K(>+9900.0%) | $230.50 K(>+9900.0%) |
| June 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2004 | -$705.50 K(-144.5%) | $0.00(0.0%) | -$705.50 K(-240.9%) |
| Sept 2004 | - | $0.00(0.0%) | $500.70 K(0.0%) |
| June 2004 | - | $0.00(-100.0%) | $500.70 K(-20.6%) |
| Mar 2004 | - | -$705.50 K(-158.5%) | $630.70 K(-60.2%) |
| Dec 2003 | $1.59 M(+358.7%) | $1.21 M(>+9900.0%) | $1.59 M(+209.9%) |
| Sept 2003 | - | $0.00(-100.0%) | $511.80 K(+36.2%) |
| June 2003 | - | $130.00 K(-48.0%) | $375.80 K(+8.7%) |
| Mar 2003 | - | $250.00 K(+89.7%) | $345.80 K(0.0%) |
| Dec 2002 | $345.80 K(-67.3%) | $131.80 K(-196.9%) | $345.80 K(-1.1%) |
| Sept 2002 | - | -$136.00 K(-236.0%) | $349.60 K(-75.3%) |
| June 2002 | - | $100.00 K(-60.0%) | $1.41 M(+7.8%) |
| Mar 2002 | - | $250.00 K(+84.4%) | $1.31 M(+23.9%) |
| Dec 2001 | $1.06 M(-79.8%) | $135.60 K(-85.4%) | $1.06 M(+15.5%) |
| Sept 2001 | - | $928.30 K(<-9900.0%) | $916.00 K(-178.6%) |
| June 2001 | - | -$2900.00(0.0%) | -$1.16 M(-124.5%) |
| Mar 2001 | - | -$2900.00(-55.4%) | $4.75 M(-9.4%) |
| Dec 2000 | $5.24 M(+904.7%) | -$6500.00(-99.4%) | $5.24 M(-0.1%) |
| Sept 2000 | - | -$1.15 M(-119.5%) | $5.25 M(-18.0%) |
| June 2000 | - | $5.91 M(+1105.7%) | $6.40 M(+1205.7%) |
| Mar 2000 | - | $490.20 K(+464.7%) | $490.20 K(+162.4%) |
| Dec 1999 | $521.70 K(+179.3%) | - | - |
| Dec 1998 | $186.80 K(+97.0%) | $86.80 K(-13.2%) | $186.80 K(+86.8%) |
| Sept 1998 | - | $100.00 K(-95.0%) | $100.00 K(-97.7%) |
| Dec 1997 | $94.80 K(-95.1%) | - | - |
| Dec 1996 | $1.94 M(-14.7%) | - | - |
| Sept 1996 | - | $2.00 M(+635.8%) | $4.27 M(+88.0%) |
| June 1996 | - | $271.80 K(-85.7%) | $2.27 M(+13.6%) |
| June 1996 | $2.27 M(+310.6%) | - | - |
| Mar 1996 | - | $1.90 M(+1800.0%) | $2.00 M(+1900.0%) |
| Dec 1995 | - | $100.00 K(0.0%) | $100.00 K(-95.8%) |
| June 1995 | $553.30 K(-75.9%) | - | - |
| Sept 1994 | - | $100.00 K(-95.2%) | $2.40 M(+4.3%) |
| June 1994 | $2.30 M(+2200.0%) | $2.10 M(+2000.0%) | $2.30 M(+1050.0%) |
| Mar 1994 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Dec 1993 | - | $100.00 K(>+9900.0%) | $100.00 K(0.0%) |
| June 1993 | $100.00 K(-99.1%) | $0.00(0.0%) | $100.00 K(0.0%) |
| Mar 1993 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| Dec 1992 | - | $100.00 K(-50.0%) | $100.00 K(-50.0%) |
| June 1992 | $11.10 M(+141.3%) | - | - |
| June 1991 | $4.60 M(+7.0%) | - | - |
| Sept 1990 | - | $200.00 K | $200.00 K |
| June 1990 | $4.30 M | - | - |
FAQ
- What is BioLife Solutions annual cash flow from financing activities?
- What is the all time high annual CFF for BioLife Solutions?
- What is BioLife Solutions annual CFF year-on-year change?
- What is BioLife Solutions quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for BioLife Solutions?
- What is BioLife Solutions quarterly CFF year-on-year change?
- What is BioLife Solutions TTM cash flow from financing activities?
- What is the all time high TTM CFF for BioLife Solutions?
- What is BioLife Solutions TTM CFF year-on-year change?
What is BioLife Solutions annual cash flow from financing activities?
The current annual CFF of BLFS is $10.59 M
What is the all time high annual CFF for BioLife Solutions?
BioLife Solutions all-time high annual cash flow from financing activities is $102.08 M
What is BioLife Solutions annual CFF year-on-year change?
Over the past year, BLFS annual cash flow from financing activities has changed by -$5.72 M (-35.09%)
What is BioLife Solutions quarterly cash flow from financing activities?
The current quarterly CFF of BLFS is -$1.04 M
What is the all time high quarterly CFF for BioLife Solutions?
BioLife Solutions all-time high quarterly cash flow from financing activities is $80.58 M
What is BioLife Solutions quarterly CFF year-on-year change?
Over the past year, BLFS quarterly cash flow from financing activities has changed by -$1.65 M (-271.22%)
What is BioLife Solutions TTM cash flow from financing activities?
The current TTM CFF of BLFS is $7.14 M
What is the all time high TTM CFF for BioLife Solutions?
BioLife Solutions all-time high TTM cash flow from financing activities is $102.80 M
What is BioLife Solutions TTM CFF year-on-year change?
Over the past year, BLFS TTM cash flow from financing activities has changed by +$7.02 M (+5615.20%)